Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lack of evidence for bromocriptine effect on glucose tolerance, insulin resistance, and body fat stores in obese type 2 diabetic patients.

× No keyword cloud information.

6 in total

1. Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.

Authors: C D Gibson; W Karmally; D J McMahon; S L Wardlaw; J Korner
Journal: Diabetes Obes Metab Date: 2011-12-27 Impact factor: 6.577

Review 2. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.

Authors: S L Norris; X Zhang; A Avenell; E Gregg; C H Schmid; J Lau
Journal: Cochrane Database Syst Rev Date: 2005-01-25

Review 3. The effects of hyperprolactinemia on bone and fat.

Authors: Amal Shibli-Rahhal; Janet Schlechte
Journal: Pituitary Date: 2009 Impact factor: 4.107

4. Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: the Graz Endocrine Causes of Hypertension study.

Authors: Andreas Tomaschitz; Eberhard Ritz; Katharina Kienreich; Burkert Pieske; Winfried März; Bernhard O Boehm; Christiane Drechsler; Andreas Meinitzer; Stefan Pilz
Journal: Diabetes Care Date: 2012-06-14 Impact factor: 19.112

5. Bromocriptine in type 2 diabetes mellitus.

Authors: C Shivaprasad; Sanjay Kalra
Journal: Indian J Endocrinol Metab Date: 2011-07

6. Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes.

Authors: Michael A Via; Himani Chandra; Takako Araki; Matthew V Potenza; Maria Skamagas
Journal: Diabetes Metab Syndr Obes Date: 2010-03-26 Impact factor: 3.168

6 in total